The general surgery devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. Biopsy entails the removal of some tissue from the body for the purpose of diagnosis or for its examination under a microscope. GlobalData uses proprietary data and analytics to provide a comprehensive report on the biopsy devices market in Australia. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the biopsy devices market in Australia was Acuderm followed by Argon Medical Devices, Becton Dickinson and Co, Boston Scientific, ConMed, Cook Medical, Henry Schein, Hologic, Integra LifeSciences, Medtronic, Merit Medical Systems, Olympus and Teleflex.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
A biopsy device is an instrument that aids in the removal of tissue samples from the body. Biopsy Guns, Vacuum-Assisted Needle devices, Biopsy Forceps, Biopsy Punches and Biopsy Needles are covered under this category. Biopsy Needles are needles used to sample small amounts of tissues from the body. Vacuum-Assisted Needle devices use a vacuum-powered system that aspirates several tissue samples rather than relying on the spring-loading mechanism seen in Biopsy Guns. Biopsy Forceps are used in association with an endoscope to obtain biopsy samples. Biopsy Guns are handheld spring-loaded devices with core needles attached. Biopsy punch has a small circular blade attached to a handle which is rotated and moved down the layers of the tissue especially the skin to obtain a cylindrical tissue sample.
The biopsy devices market in Australia can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size biopsy devices in Australia, buy the report here.